Analysis

Global HCP Transparency Study

Regulatory disclosure challenges and program guidance for Life Sciences companies

Can the game be changed? Is there an opportunity for the life sciences industry to come together—formally—to develop a global HCP transparency solution?

HCP Global Transparency Study: Regulatory disclosure challenges and program guidance for Life Sciences companies

Download PDF

Learn more about the Global HCP Transparency Study

HCP transparency requirements are similar in many countries which have existing laws and industry codes: the data elements are similar; the processes to collect and report the data are similar; and the roles and responsibilities required to operate a HCP transparency reporting solution are similar. Despite these similarities, however, we have observed that many companies are building essentially redundant systems, processes, and organizations in each country with a current or pending HCP transparency regulation.

 

Meet the authors

Mike DeLone

Mike DeLone

Enterprise Technology Leader | Life Sciences

Mike is a principal in Deloitte Consulting’s Life ...More

Greg Reh

Greg Reh

DTTL Global Life Sciences Sector Leader

Greg is the DTTL Global Life Sciences Sector Leade...More

Contact us

Contact us via our online form

Submit RFP

Submit via our online form

Find an office

Find a local office